News

The IRISCAT starts a series of webinars focussed on COVID-19 research

- Institutional

The Catalan Alliance for Insitutes for Research and Innovation in Health (IRISCAT) has launched its first science communications activity in a series of webinars to share different topics of biomedical research into COVID-19. These on-line research seminars will take place every 2 weeks, the first will be given by Dr Manel Puig of the Germans Trias i Pujol Research Insitute on 27 May at 16.00.

Not only does this adapt to the new reality imposed by the coronavirus, but it is designed to allow access for the maximum number of interested researchers. The seminars will also be recorded so they will be available online.

This first series will consist of 6 seminars that will alternate clinical and basic research on COVID-19 during the coming weeks. The second series, after the summer, will be programmed soon.

The first seminar will be

Why diabetes and metabolic syndrome account for a worse outcome in COVID-19 infection?

Dr. Manuel Puig Domingo, Acting Director of the IGTP and Head of the Endocrinology and Nutrition Service at the Germans Trias i Pujol Hospital.

Please sign up for the seminar at the following link
Registration is free 

IRISCAT COVID-19 Research Seminars

27 May 16.00
Why diabetes and metabolic syndrome account for a worse outcome in COVID-19 infection?
Dr. Manuel Puig Domingo, Acting Director of the IGTP and Head of the Endocrinology and Nutrition Service at the Germans Trias i Pujol Hospital
 

Dates to be confirmed:


Results of the clinical trial with Remdesivir
  
Dr Roger Paredes, IrsiCaixa, Fight AIDS Foundation and Germans Trias i Pujol Hospital

Clinical Trial wiht TOCOVID
  
Dr Pere Domingo, Santa Creu i Sant Pau Hospital


Development of the SARS-CoV-2 vaccines
  
Dr Julià Blanco, IrsiCaixa and IGTP


Poxvirus and vaccines  Development of a vaccine for COVID-19
  
Dr Mariano Esteban and Dr Luis Enjuanes, Consejo Superior de Investigaciones Científicas (CSIC)


Modelling the COVID-19 Pandemic
  
Dr Clara Prats, Universitat Politècnica de Catalunya BarcelonaTech (UPC) and IGTP